First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume 18, Issue 3, Pages 531-540

出版商

American Association for Cancer Research (AACR)

发表日期

2019-01-25

DOI

10.1158/1535-7163.mct-18-0831

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started